As agentic systems mature toward continuous, autonomous refactoring, the concept of "legacy code" may eventually disappear ...

Gemini has got new powers to better visualize science concepts. The feature is rolling out to all users except those in ...

Linking Gemini directly to a user's photo library represents a bigger step in the AI chatbot link to private information.

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

JDK 26 moves to general production availability. This short-term release is backed by six months of Premier-level support. Java Development Kit (JDK) 26, the latest standard Java release from Oracle, ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Explore the top AI certifications to boost your career and validate your AI skills. Find the best programs in machine ...

In the future, the professional believes the convergence of AI, automation, human collaboration will define the next decade ...

Hays' Tech Talent Explorer examines how AI is influencing tech roles globally, highlighting the technology's role in augmenting human expertise. It also benchmarks global salaries across key tech role ...